Harbin Gloria Pharmaceuticals (002437.SZ) Earnings Analysis
Harbin Gloria Pharmaceuticals (002437.SZ) has no confirmed upcoming earnings date. Trailing P/E 15.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002437.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 002437.SZ. This page updates as the calendar is published.
002437.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-15 | 0.0608 CNY | n/a | n/a | n/a |
| 2025-10-29 | 0.0487 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.03274 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.0266 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.02177 CNY | n/a | n/a | n/a |
002437.SZ valuation and analyst view
| Trailing P/E | 15.28 |
|---|---|
| Trailing EPS | 0.18774 CNY |
| Price / book | 2.63 |
| Dividend yield | 0.00% |
| Market cap | 6.31B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Harbin Gloria Pharmaceuticals (002437.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 002437.SZ. This page updates as the calendar is published.
Did 002437.SZ beat earnings last quarter?
Consensus estimate data was not available for 002437.SZ's 2026-04-15 report.
What is 002437.SZ's current P/E ratio and EPS?
002437.SZ trades at a trailing P/E of 15.28 on trailing EPS of 0.1877394724919798 CNY.
What do analysts rate 002437.SZ?
002437.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.